Dermatologic symptoms associated with the multikinase inhibitor sorafenib
- 28 February 2009
- journal article
- review article
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 60 (2), 299-305
- https://doi.org/10.1016/j.jaad.2008.06.034
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Body Fatness at Young Ages and Risk of Breast Cancer Throughout LifeAmerican Journal of Epidemiology, 2010
- Environmental Causes of Esophageal CancerGastroenterology Clinics of North America, 2009
- High‐temperature beverages and foods and esophageal cancer risk—A systematic reviewInternational Journal of Cancer, 2009
- Physical Activity and Esophageal and Gastric Carcinoma in a Large Prospective StudyAmerican Journal of Preventive Medicine, 2009
- Body size in early life and risk of epithelial ovarian cancer: results from the Nurses' Health StudiesBritish Journal of Cancer, 2008
- Opium, tobacco, and alcohol use in relation to oesophageal squamous cell carcinoma in a high-risk area of IranBritish Journal of Cancer, 2008
- Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studiesThe Lancet, 2008
- Keratoacanthomas associated with sorafenib therapyJournal of the American Academy of Dermatology, 2007
- Sorafenib in Advanced Clear-Cell Renal-Cell CarcinomaNew England Journal of Medicine, 2007
- Targeting RAS signalling pathways in cancer therapyNature Reviews Cancer, 2003